Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Incyte Biosciences International Sàrl

Clinical trials sponsored by Incyte Biosciences International Sàrl, explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1

New Triple-Drug cocktail aims to shrink head and neck tumors

Disease control Ongoing

This study tests whether adding two experimental drugs (INCAGN02385 and INCAGN02390) to the immunotherapy retifanlimab can better control advanced head and neck cancer that has returned or spread. About 176 adults with PD-L1-positive tumors who have not had prior systemic therapy…

Phase: PHASE2 • Sponsor: Incyte Biosciences International Sàrl • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC